1. Gershon AA. Varicella-zoster virus. In : Cherry DS, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Fiegin and Cherry's textbook of pediatric infectious diseases. 17th ed. Philadelphia, PA: Saunders;2014. p. 2021–2033.
2. Sørensen GV, Rosthøj S, Würtz M, Danielsen TK, Schrøder H. The epidemiology of herpes zoster in 226 children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011; 57:993–997. PMID:
21254379.
Article
3. Bovill B, Bannister B. Review of 26 years' hospital admissions for chickenpox in North London. J Infect. 1998; 36(Suppl 1):17–23.
Article
4. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: Seventy-seven cases. Pediatrics. 1975; 56:388–397. PMID:
1088828.
5. Feldman S, Hughes WT, Kim HY. Herpes zoster in children with cancer. Am J Dis Child. 1973; 126:178–184. PMID:
4353308.
Article
6. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics. 1987; 80:465–472. PMID:
2821476.
Article
7. Morgan ER, Smalley LA. Varicella in immunocompromised children. Incidence of abdominal pain and organ involvement. Am J Dis Child. 1983; 137:883–885. PMID:
6613954.
8. Gershon AA. Varicella-zoster virus infections. Pediatr Rev. 2008; 29:5–10. PMID:
18166616.
Article
9. Novelli VM, Brunell PA, Geiser CF, Narkewicz S, Frierson L. Herpes zoster in children with acute lymphocytic leukemia. Am J Dis Child. 1988; 142:71–72. PMID:
3277389.
Article
10. Ljungman P, Lönnqvist B, Gahrton G, Ringdén O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis. 1986; 153:840–847. PMID:
3009635.
Article
11. Rowland P, Wald ER, Mirro JR Jr, et al. Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia. J Clin Oncol. 1995; 13:1697–1703. PMID:
7602360.
Article
12. Mubareka S, Leung V, Aoki FY, Vinh DC. Famciclovir: a focus on efficacy and safety. Expert Opin Drug Saf. 2010; 9:643–658. PMID:
20429777.
Article
13. Vigil KJ, Chemaly RF. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert Opin Pharmacother. 2010; 11:1901–1913. PMID:
20536295.
Article
14. Sáez-Llorens X, Yogev R, Arguedas A, et al. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection. Antimicrob Agents Chemother. 2009; 53:1912–1920. PMID:
19273678.
Article
15. Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney S. Valacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatr Blood Cancer. 2008; 51:504–508. PMID:
18561175.
Article
16. Hill G, Chauvenet AR, Lovato J, McLean TW. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. Pediatrics. 2005; 116:e525–e529. PMID:
16199681.
Article
17. Brunell PA, Taylor-Wiedeman J, Geiser CF, Frierson L, Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 1986; 77:53–56. PMID:
3455669.
Article
18. Patel SR, Bate J, Maple PA, Brown K, Breuer J, Heath PT. Varicella zoster immune status in children treated for acute leukemia. Pediatr Blood Cancer. 2014; 61:2077–2079. PMID:
24789692.
Article
19. Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis. 2016; 35:723–734. PMID:
26873382.
Article